AI Science Tracker
EN

Utilizing machine learning and MALDI-TOF MS platform for rapid detection of ceftriaxone-resistant nontyphoidal Salmonella.

Affiliation not stated in the reviewed material · 28 Sep 2026 · medicine

Discovery

Utilizing machine learning and MALDI-TOF MS platform for rapid detection of ceftriaxone-resistant nontyphoidal Salmonella.

Source check: Source checked. Not independent scientific confirmation.

Finding: LightGBM on MALDI-TOF spectra predicted ceftriaxone resistance among nontyphoidal Salmonella isolates, with internal and two external-center evaluations.

Technology: LightGBM classifier on MALDI-TOF mass spectra

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods describe 472 pediatric isolates, spectra and validation cohorts; Results report resistance classification on internal and external cohorts. PubMed ArticleDate 2026-09-28 precedes later journal issue date.
Test and result
Methods describe 472 pediatric isolates, spectra and validation cohorts; Results report resistance classification on internal and external cohorts. PubMed ArticleDate 2026-09-28 precedes later journal issue date.
Limitation / still unknown
Methods describe 472 pediatric isolates, spectra and validation cohorts; Results report resistance classification on internal and external cohorts. PubMed ArticleDate 2026-09-28 precedes later journal issue date.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&id=PMC13729124

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.